ArticlemBio2022

Evidence for an ACE2-Independent Entry Pathway That Can Protect from Neutralization by an Antibody Used for COVID-19 Therapy.

Markus Hoffmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.